Dr. Mustafa Diken

Mustafa Diken received his Ph.D. in tumor immunology from Johannes Gutenberg University, Mainz and is currently the Deputy Head of the Department for Immune Therapy Development at TRON gGmbH.

His research focuses on the development of novel cancer vaccines based on antigen-encoding messenger RNA (mRNA) and the elucidation of immunomodulatory mechanisms for cancer immunotherapy. His other scientific interests include the use of non-invasive in vivo bioluminescence and fluorescence imaging techniques for preclinical testing of cancer vaccines. Mustafa also serves as scientific secretary of the Association for Cancer Immunotherapy (CIMT), a non-profit organization aimed at advancing cancer immunotherapy.

Mustafa Diken